Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes
Open Access
- 8 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 66 (8), 1839-1846
- https://doi.org/10.1093/jac/dkr200
Abstract
To investigate the clinical impact of different genospecies of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex (ACB complex; A. baumannii, Acinetobacter gen. sp. 13TU and Acinetobacter gen. sp. 3) on the severity of bacteraemia. We retrospectively compared the clinical features and outcomes of patients with bacteraemia caused by A. baumannii, Acinetobacter gen. sp. 13TU or Acinetobacter gen. sp. 3. The genospecies were identified using oligonucleotide array sequence analysis (interspacer sequence), and the clonality of Acinetobacter gen. sp. 13TU and 3 isolates was determined by PFGE analysis. A total of 215 patients with bacteraemia due to ACB complex were evaluated. Among them, 117 (54.4%) had A. baumannii bacteraemia, 77 (35.8%) had Acinetobacter gen. sp. 13TU bacteraemia and 21 (9.8%) had Acinetobacter gen. sp. 3 bacteraemia. A. baumannii bacteraemia was associated with a higher 14 day mortality rate (P < 0.001), a higher 30 day mortality rate (P < 0.001) and a higher in-hospital mortality rate than bacteraemia due to Acinetobacter gen. sp. 13TU or Acinetobacter gen. sp. 3. Independent prognostic factors for the 30 day mortality included the Charlson co-morbidity index (P < 0.001) and Pitt bacteraemia score (P < 0.001). Bloodstream infection caused by a multidrug-resistant A. baumannii isolate appeared to be associated with a poor outcome (P = 0.069). There was no clonal spread of Acinetobacter gen. sp. 13TU or Acinetobacter gen. sp. 3 during the study period. Bacteraemia due to multidrug-resistant strains but not A. baumannii per se appears to be associated with poor outcome.Keywords
This publication has 28 references indexed in Scilit:
- Acinetobacter baumannii : Emergence of a Successful PathogenClinical Microbiology Reviews, 2008
- Oligonucleotide Array-Based Identification of Species in the Acinetobacter calcoaceticus-A. baumannii Complex in Isolates from Blood Cultures and Antimicrobial Susceptibility Testing of the IsolatesJournal of Clinical Microbiology, 2008
- Application of a Microsphere-Based Array for Rapid Identification of Acinetobacter spp. with Distinct Antimicrobial SusceptibilitiesJournal of Clinical Microbiology, 2008
- An increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNature Reviews Microbiology, 2007
- Multicenter Studies of Tigecycline Disk Diffusion Susceptibility Results for Acinetobacter sppJournal of Clinical Microbiology, 2007
- Sequencing of the rpoB Gene and Flanking Spacers for Molecular Identification of Acinetobacter SpeciesJournal of Clinical Microbiology, 2006
- Standardization and Interlaboratory Reproducibility Assessment of Pulsed-Field Gel Electrophoresis-Generated Fingerprints of Acinetobacter baumanniiJournal of Clinical Microbiology, 2005
- Species-Level Identification of Isolates of the Acinetobacter calcoaceticus - Acinetobacter baumannii Complex by Sequence Analysis of the 16S-23S rRNA Gene Spacer RegionJournal of Clinical Microbiology, 2005
- Evaluation of Amplified Ribosomal DNA Restriction Analysis for Identification of Acinetobacter Genomic SpeciesSystematic and Applied Microbiology, 1998
- Discrimination of Acinetobacter Genomic Species by AFLP FingerprintingInternational Journal of Systematic and Evolutionary Microbiology, 1997